Global Meningococcal Conjugate Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Meningococcal Conjugate Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Conjugate Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Menactra
1.2.3 Menveo
1.2.4 NeisVac-C
1.2.5 Nimenrix
1.2.6 Others
1.3 Market by End User
1.3.1 Global Meningococcal Conjugate Market Growth Rate by End User: 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Preteens or Teens
1.3.4 Adults
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Meningococcal Conjugate Market Size (2017-2028)
2.2 Meningococcal Conjugate Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Meningococcal Conjugate Market Size by Region (2017-2022)
2.4 Global Meningococcal Conjugate Market Size Forecast by Region (2023-2028)
2.5 Global Top Meningococcal Conjugate Countries Ranking by Market Size
3 Meningococcal Conjugate Competitive by Company
3.1 Global Meningococcal Conjugate Revenue by Players
3.1.1 Global Meningococcal Conjugate Revenue by Players (2017-2022)
3.1.2 Global Meningococcal Conjugate Market Share by Players (2017-2022)
3.2 Global Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Meningococcal Conjugate Revenue
3.4 Global Meningococcal Conjugate Market Concentration Ratio
3.4.1 Global Meningococcal Conjugate Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Conjugate Revenue in 2021
3.5 Global Meningococcal Conjugate Key Players Head office and Area Served
3.6 Key Players Meningococcal Conjugate Product Solution and Service
3.7 Date of Enter into Meningococcal Conjugate Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Meningococcal Conjugate Breakdown Data by Type
4.1 Global Meningococcal Conjugate Historic Revenue by Type (2017-2022)
4.2 Global Meningococcal Conjugate Forecasted Revenue by Type (2023-2028)
5 Global Meningococcal Conjugate Breakdown Data by End User
5.1 Global Meningococcal Conjugate Historic Market Size by End User (2017-2022)
5.2 Global Meningococcal Conjugate Forecasted Market Size by End User (2023-2028)
6 North America
6.1 North America Meningococcal Conjugate Revenue by Company (2020-2022)
6.2 North America Meningococcal Conjugate Revenue by Type (2017-2028)
6.3 North America Meningococcal Conjugate Revenue by End User (2017-2028)
6.4 North America Meningococcal Conjugate Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Meningococcal Conjugate Revenue by Company (2020-2022)
7.2 Europe Meningococcal Conjugate Revenue by Type (2017-2028)
7.3 Europe Meningococcal Conjugate Revenue by End User (2017-2028)
7.4 Europe Meningococcal Conjugate Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Meningococcal Conjugate Revenue by Company (2020-2022)
8.2 Asia Pacific Meningococcal Conjugate Revenue by Type (2017-2028)
8.3 Asia Pacific Meningococcal Conjugate Revenue by End User (2017-2028)
8.4 Asia Pacific Meningococcal Conjugate Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Meningococcal Conjugate Revenue by Company (2020-2022)
9.2 Latin America Meningococcal Conjugate Revenue by Type (2017-2028)
9.3 Latin America Meningococcal Conjugate Revenue by End User (2017-2028)
9.4 Latin America Meningococcal Conjugate Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Meningococcal Conjugate Revenue by Company (2020-2022)
10.2 Middle East and Africa Meningococcal Conjugate Revenue by Type (2017-2028)
10.3 Middle East and Africa Meningococcal Conjugate Revenue by End User (2017-2028)
10.4 Middle East and Africa Meningococcal Conjugate Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Details
11.1.2 Sanofi Pasteur Business Overview
11.1.3 Sanofi Pasteur Meningococcal Conjugate Products and Services
11.1.4 Sanofi Pasteur Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022)
11.1.5 Sanofi Pasteur Meningococcal Conjugate SWOT Analysis
11.1.6 Sanofi Pasteur Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Meningococcal Conjugate Products and Services
11.2.4 Pfizer Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022)
11.2.5 Pfizer Meningococcal Conjugate SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Glaxo Smith Kline
11.3.1 Glaxo Smith Kline Company Details
11.3.2 Glaxo Smith Kline Business Overview
11.3.3 Glaxo Smith Kline Meningococcal Conjugate Products and Services
11.3.4 Glaxo Smith Kline Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022)
11.3.5 Glaxo Smith Kline Meningococcal Conjugate SWOT Analysis
11.3.6 Glaxo Smith Kline Recent Developments
11.4 Hualan Biological Engineering
11.4.1 Hualan Biological Engineering Company Details
11.4.2 Hualan Biological Engineering Business Overview
11.4.3 Hualan Biological Engineering Meningococcal Conjugate Products and Services
11.4.4 Hualan Biological Engineering Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022)
11.4.5 Hualan Biological Engineering Meningococcal Conjugate SWOT Analysis
11.4.6 Hualan Biological Engineering Recent Developments
11.5 JN International Medical Corporation
11.5.1 JN International Medical Corporation Company Details
11.5.2 JN International Medical Corporation Business Overview
11.5.3 JN International Medical Corporation Meningococcal Conjugate Products and Services
11.5.4 JN International Medical Corporation Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022)
11.5.5 JN International Medical Corporation Meningococcal Conjugate SWOT Analysis
11.5.6 JN International Medical Corporation Recent Developments
11.6 Baxter International
11.6.1 Baxter International Company Details
11.6.2 Baxter International Business Overview
11.6.3 Baxter International Meningococcal Conjugate Products and Services
11.6.4 Baxter International Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022)
11.6.5 Baxter International Meningococcal Conjugate SWOT Analysis
11.6.6 Baxter International Recent Developments
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Meningococcal Conjugate Products and Services
11.7.4 Merck Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022)
11.7.5 Merck Meningococcal Conjugate SWOT Analysis
11.7.6 Merck Recent Developments
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Details
11.8.2 Serum Institute of India Business Overview
11.8.3 Serum Institute of India Meningococcal Conjugate Products and Services
11.8.4 Serum Institute of India Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022)
11.8.5 Serum Institute of India Meningococcal Conjugate SWOT Analysis
11.8.6 Serum Institute of India Recent Developments
11.9 Biomed
11.9.1 Biomed Company Details
11.9.2 Biomed Business Overview
11.9.3 Biomed Meningococcal Conjugate Products and Services
11.9.4 Biomed Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022)
11.9.5 Biomed Meningococcal Conjugate SWOT Analysis
11.9.6 Biomed Recent Developments
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Meningococcal Conjugate Products and Services
11.10.4 Novartis Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022)
11.10.5 Novartis Meningococcal Conjugate SWOT Analysis
11.10.6 Novartis Recent Developments
12 Meningococcal Conjugate Market Dynamics
12.1 Meningococcal Conjugate Market Trends
12.2 Meningococcal Conjugate Market Drivers
12.3 Meningococcal Conjugate Market Challenges
12.4 Meningococcal Conjugate Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Meningococcal Conjugate Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Menactra
Table 3. Key Players of Menveo
Table 4. Key Players of NeisVac-C
Table 5. Key Players of Nimenrix
Table 6. Key Players of Others
Table 7. Global Meningococcal Conjugate Market Size Growth Rate by End User (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Meningococcal Conjugate Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Meningococcal Conjugate Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Meningococcal Conjugate Revenue Market Share by Region (2017-2022)
Table 11. Global Meningococcal Conjugate Revenue by Players (2017-2022) & (US$ Million)
Table 12. Global Meningococcal Conjugate Market Share by Players (2017-2022)
Table 13. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2021)
Table 14. Ranking of Global Top Meningococcal Conjugate Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by Meningococcal Conjugate Revenue (CR5 and HHI) & (2017-2022)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players Meningococcal Conjugate Product Solution and Service
Table 18. Date of Key Manufacturers Enter into Meningococcal Conjugate Market
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Meningococcal Conjugate Market Size by Type (2017-2022) & (US$ Million)
Table 21. Global Meningococcal Conjugate Revenue Market Share by Type (2017-2022)
Table 22. Global Meningococcal Conjugate Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 23. Global Meningococcal Conjugate Revenue Market Share by Type (2023-2028)
Table 24. Global Meningococcal Conjugate Market Size by End User (2017-2022) & (US$ Million)
Table 25. Global Meningococcal Conjugate Revenue Market Share by End User (2017-2022)
Table 26. Global Meningococcal Conjugate Forecasted Market Size by End User (2023-2028) & (US$ Million)
Table 27. Global Meningococcal Conjugate Revenue Market Share by End User (2023-2028)
Table 28. North America Meningococcal Conjugate Revenue by Company (2020-2022) & (US$ Million)
Table 29. North America Meningococcal Conjugate Revenue by Type (2017-2022) & (US$ Million)
Table 30. North America Meningococcal Conjugate Revenue by Type (2023-2028) & (US$ Million)
Table 31. North America Meningococcal Conjugate Revenue by End User (2017-2022) & (US$ Million)
Table 32. North America Meningococcal Conjugate Revenue by End User (2023-2028) & (US$ Million)
Table 33. North America Meningococcal Conjugate Revenue by Country (2017-2022) & (US$ Million)
Table 34. North America Meningococcal Conjugate Revenue by Country (2023-2028) & (US$ Million)
Table 35. Europe Meningococcal Conjugate Revenue by Company (2020-2022) & (US$ Million)
Table 36. Europe Meningococcal Conjugate Revenue by Type (2017-2022) & (US$ Million)
Table 37. Europe Meningococcal Conjugate Revenue by Type (2023-2028) & (US$ Million)
Table 38. Europe Meningococcal Conjugate Revenue by End User (2017-2022) & (US$ Million)
Table 39. Europe Meningococcal Conjugate Revenue by End User (2023-2028) & (US$ Million)
Table 40. Europe Meningococcal Conjugate Revenue by Country (2017-2022) & (US$ Million)
Table 41. Europe Meningococcal Conjugate Revenue by Country (2023-2028) & (US$ Million)
Table 42. Asia Pacific Meningococcal Conjugate Revenue by Company (2020-2022) & (US$ Million)
Table 43. Asia Pacific Meningococcal Conjugate Revenue by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Meningococcal Conjugate Revenue by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Meningococcal Conjugate Revenue by End User (2017-2022) & (US$ Million)
Table 46. Asia Pacific Meningococcal Conjugate Revenue by End User (2023-2028) & (US$ Million)
Table 47. Asia Pacific Meningococcal Conjugate Revenue by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Meningococcal Conjugate Revenue by Region (2023-2028) & (US$ Million)
Table 49. Latin America Meningococcal Conjugate Revenue by Company (2020-2022) & (US$ Million)
Table 50. Latin America Meningococcal Conjugate Revenue by Type (2017-2022) & (US$ Million)
Table 51. Latin America Meningococcal Conjugate Revenue by Type (2023-2028) & (US$ Million)
Table 52. Latin America Meningococcal Conjugate Revenue by End User (2017-2022) & (US$ Million)
Table 53. Latin America Meningococcal Conjugate Revenue by End User (2023-2028) & (US$ Million)
Table 54. Latin America Meningococcal Conjugate Revenue by Country (2017-2022) & (US$ Million)
Table 55. Latin America Meningococcal Conjugate Revenue by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Meningococcal Conjugate Revenue by Company (2020-2022) & (US$ Million)
Table 57. Middle East and Africa Meningococcal Conjugate Revenue by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Meningococcal Conjugate Revenue by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Meningococcal Conjugate Revenue by End User (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Meningococcal Conjugate Revenue by End User (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Meningococcal Conjugate Revenue by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Meningococcal Conjugate Revenue by Country (2023-2028) & (US$ Million)
Table 63. Sanofi Pasteur Company Details
Table 64. Sanofi Pasteur Business Overview
Table 65. Sanofi Pasteur Meningococcal Conjugate Product and Services
Table 66. Sanofi Pasteur Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 67. Sanofi Pasteur Meningococcal Conjugate SWOT Analysis
Table 68. Sanofi Pasteur Recent Developments
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Meningococcal Conjugate Product and Services
Table 72. Pfizer Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 73. Pfizer Meningococcal Conjugate SWOT Analysis
Table 74. Pfizer Recent Developments
Table 75. Glaxo Smith Kline Company Details
Table 76. Glaxo Smith Kline Business Overview
Table 77. Glaxo Smith Kline Meningococcal Conjugate Product and Services
Table 78. Glaxo Smith Kline Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 79. Glaxo Smith Kline Meningococcal Conjugate SWOT Analysis
Table 80. Glaxo Smith Kline Recent Developments
Table 81. Hualan Biological Engineering Company Details
Table 82. Hualan Biological Engineering Business Overview
Table 83. Hualan Biological Engineering Meningococcal Conjugate Product and Services
Table 84. Hualan Biological Engineering Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 85. Hualan Biological Engineering Meningococcal Conjugate SWOT Analysis
Table 86. Hualan Biological Engineering Recent Developments
Table 87. JN International Medical Corporation Company Details
Table 88. JN International Medical Corporation Business Overview
Table 89. JN International Medical Corporation Meningococcal Conjugate Product and Services
Table 90. JN International Medical Corporation Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 91. JN International Medical Corporation Meningococcal Conjugate SWOT Analysis
Table 92. JN International Medical Corporation Recent Developments
Table 93. Baxter International Company Details
Table 94. Baxter International Business Overview
Table 95. Baxter International Meningococcal Conjugate Product and Services
Table 96. Baxter International Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 97. Baxter International Meningococcal Conjugate SWOT Analysis
Table 98. Baxter International Recent Developments
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Meningococcal Conjugate Product and Services
Table 102. Merck Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 103. Merck Meningococcal Conjugate SWOT Analysis
Table 104. Merck Recent Developments
Table 105. Serum Institute of India Company Details
Table 106. Serum Institute of India Business Overview
Table 107. Serum Institute of India Meningococcal Conjugate Product and Services
Table 108. Serum Institute of India Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 109. Serum Institute of India Meningococcal Conjugate SWOT Analysis
Table 110. Serum Institute of India Recent Developments
Table 111. Biomed Company Details
Table 112. Biomed Business Overview
Table 113. Biomed Meningococcal Conjugate Product and Services
Table 114. Biomed Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 115. Biomed Meningococcal Conjugate SWOT Analysis
Table 116. Biomed Recent Developments
Table 117. Novartis Company Details
Table 118. Novartis Business Overview
Table 119. Novartis Meningococcal Conjugate Product and Services
Table 120. Novartis Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 121. Novartis Meningococcal Conjugate SWOT Analysis
Table 122. Novartis Recent Developments
Table 123. Meningococcal Conjugate Market Trends
Table 124. Meningococcal Conjugate Market Drivers
Table 125. Meningococcal Conjugate Market Challenges
Table 126. Meningococcal Conjugate Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meningococcal Conjugate Sales Market Share by Type: 2021 VS 2028
Figure 2. Menactra Features
Figure 3. Menveo Features
Figure 4. NeisVac-C Features
Figure 5. Nimenrix Features
Figure 6. Others Features
Figure 7. Global Meningococcal Conjugate Sales Market Share by End User: 2021 VS 2028
Figure 8. Children Case Studies
Figure 9. Preteens or Teens Case Studies
Figure 10. Adults Case Studies
Figure 11. Meningococcal Conjugate Report Years Considered
Figure 12. Global Meningococcal Conjugate Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Meningococcal Conjugate Market Size 2017-2028 (US$ Million)
Figure 14. Global Meningococcal Conjugate Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Meningococcal Conjugate Revenue Market Share by Region in 2017 VS 2022
Figure 16. Global Top 10 Meningococcal Conjugate Countries Ranking by Market Size (US$ Million) in 2021
Figure 17. Global Meningococcal Conjugate Market Share by Players in 2021
Figure 18. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Meningococcal Conjugate Revenue in 2021
Figure 20. North America Meningococcal Conjugate Revenue Market Share by Company in 2021
Figure 21. North America Meningococcal Conjugate Revenue Market Share by Type (2017-2028)
Figure 22. North America Meningococcal Conjugate Revenue Market Share by End User (2017-2028)
Figure 23. North America Meningococcal Conjugate Revenue Share by Country (2017-2028)
Figure 24. U.S. Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 25. Canada Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 26. Europe Meningococcal Conjugate Revenue Market Share by Company in 2021
Figure 27. Europe Meningococcal Conjugate Revenue Market Share by Type (2017-2028)
Figure 28. Europe Meningococcal Conjugate Revenue Market Share by End User (2017-2028)
Figure 29. Europe Meningococcal Conjugate Revenue Share by Country (2017-2028)
Figure 30. Germany Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 31. France Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 32. U.K. Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 33. Italy Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 34. Russia Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Meningococcal Conjugate Revenue Market Share by Company in 2021
Figure 36. Asia Pacific Meningococcal Conjugate Revenue Market Share by Type (2017-2028)
Figure 37. Asia Pacific Meningococcal Conjugate Revenue Market Share by End User (2017-2028)
Figure 38. Asia Pacific Meningococcal Conjugate Revenue Share by Region (2017-2028)
Figure 39. China Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 40. Japan Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 41. South Korea Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 42. India Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 43. Australia Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 44. Taiwan Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 45. Indonesia Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 46. Thailand Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 47. Malaysia Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 48. Philippines Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 49. Vietnam Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 50. Latin America Meningococcal Conjugate Revenue Market Share by Company in 2021
Figure 51. Latin America Meningococcal Conjugate Revenue Market Share by Type (2017-2028)
Figure 52. Latin America Meningococcal Conjugate Revenue Market Share by End User (2017-2028)
Figure 53. Latin America Meningococcal Conjugate Revenue Share by Country (2017-2028)
Figure 54. Mexico Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 55. Brazil Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 56. Argentina Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 57. Middle East and Africa Meningococcal Conjugate Revenue Market Share by Company in 2021
Figure 58. Middle East and Africa Meningococcal Conjugate Revenue Market Share by Type (2017-2028)
Figure 59. Middle East and Africa Meningococcal Conjugate Revenue Market Share by End User (2017-2028)
Figure 60. Middle East and Africa Meningococcal Conjugate Revenue Share by Country (2017-2028)
Figure 61. Turkey Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 62. Saudi Arabia Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 63. U.A.E Meningococcal Conjugate Revenue (2017-2028) & (US$ Million)
Figure 64. Sanofi Pasteur Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 65. Pfizer Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 66. Glaxo Smith Kline Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 67. Hualan Biological Engineering Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 68. JN International Medical Corporation Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 69. Baxter International Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 70. Merck Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 71. Serum Institute of India Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 72. Biomed Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 73. Novartis Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs